IBVTA Statement on Non-Compliant E-Cigarette Products.

Mar.22.2023
IBVTA Statement on Non-Compliant E-Cigarette Products.
UK e-cigarette association IBVTA responds to BAT's non-compliant vape product incident, emphasizing the importance of regulatory compliance in the industry.

On March 21, the Independent British Vaping Trade Association (IBVTA) released a statement regarding the incident involving BAT UK's submission of disposable e-cigarettes for testing.


IBVTA stated in a declaration that it will not tolerate non-compliant electronic cigarette products, and all manufacturers in the industry must comply with regulations in the most stringent manner. Anyone who intentionally or unintentionally violates these regulations poses a real threat to both consumers and the industry.


The IBVTA states its aim is to ensure compliance in the market, but also expresses concern that the tobacco industry and its subsidiaries are using the non-compliance of these few products to establish the viewpoint that the independent e-cigarette industry is untrustworthy.


The IBVTA has stated that electronic cigarette products are considered to be less addictive than combustible cigarettes. However, BAT's decision to withdraw electronic cigarette products from the market in order to meet compliance targets may potentially lead individuals who use e-cigarettes to revert back to smoking combustible cigarettes, which is BAT's primary business.


The IBVTA believes that the media has failed to report on the details and engage in a balanced dialogue with retailers and wholesalers, instead portraying electronic cigarettes as a "negative news story.


Therefore, any statement made by BAT regarding reducing harm should now be questioned.


The IBVTA itself will not act as a law enforcement agency, but they will report any non-compliant issues in the industry to the relevant authorities.


The following is a translation of the original statement from IBVTA:


We believe that certain restrictions on e-cigarette products should be revised. Nonetheless, the notification process under the EU Tobacco and Related Products Regulations (TRPR) has established a solid framework in history for manufacturers and the wider industry to take action and ensure good governance of product standards.


Manufacturers have a vital responsibility to abide by regulations in the most stringent manner possible. Retailers must also ensure they only sell products that have been notified and assume the manufacturer has provided products that meet necessary regulatory requirements. While many distributors are now implementing their own due diligence checks, adding further layers of scrutiny, ensuring they strictly comply with regulations remains the primary responsibility of notifiers/manufacturers.


Anyone who intentionally or unintentionally violates these regulations must take swift action to bring their products back into compliance and follow the reporting process under the guidance of regulatory agencies.


Illegal products are flooding the UK market in the form of electronic liquids containing up to 20 milliliters, without providing safety or toxicity testing to the Medicines and Healthcare Products Regulatory Agency. This issue demands equal or greater attention, as it poses a genuine threat to consumers and the industry. Equally guilty are the retailers who choose to sell these products or claim ignorance about their source. As an industry, we must continue to provide support and resources to enable enforcement agencies to take action.


Unfortunately, we have recently learned that some manufacturers have issued notifications about their products but are allegedly violating or have been found to be in violation of these regulations. Some importers have relied on the promises of these manufacturers and have not carried out any further product due diligence. Even if the non-compliance issues are of a technical nature and do not directly involve any consumer safety risks, this will have a negative impact on the electronic cigarette industry.


Therefore, all parties involved must cooperate to ensure the implementation of discipline and multi-level due diligence. The independent e-cigarette industry has been working hard for more than a decade, establishing this market and steering e-cigarettes towards becoming the most popular, effective, and economical smoking cessation tool. Continuing to achieve success and confidence is crucial for this industry.


It has become evident that certain products, which should have been in compliance with regulations, have been found to contain technical non-compliances. This has had an impact on relevant parties. Some of these products have been entirely removed from the supply chain, or further supplies have been withdrawn until they meet compliance requirements. Brands that are aware of this situation are striving to provide fully compliant products to the UK market as quickly as possible. Our goal is to ensure that the market is in compliance as smoothly and swiftly as possible.


In recent weeks, the IBVTA (Independent British Vape Trade Association) has engaged in constructive cooperation with regulatory agencies, law enforcement agencies, and its members to foster dialogue and provide members with best practices advice from law enforcement agencies. We also encourage our members and their partners to regularly update completed corrective actions, as well as upcoming or future actions. We understand that these updates are being provided regularly.


Despite all of this, the IBVTA is increasingly concerned that the tobacco industry and its affiliates are using these few instances of noncompliance to build a narrative that the independent vaping industry is untrustworthy. Additionally, we are worried about the way this is being done; sometimes incorrect law enforcement terminology is used, risks of overfilling products are exaggerated, and the tasks of regulatory agencies, law enforcement agencies, and industry participants are being distorted.


While we acknowledge the findings of BAT's report and the impact it has had on promoting greater compliance, it's important to recognize that electronic cigarettes are known to reduce harmful effects by at least 95% compared to BAT's lethal core products. They are also believed to be less addictive than combustible cigarettes. The controversy surrounding them revolves around a non-compliant technical issue, meaning they may have a slightly longer lifespan. The issue is not about product safety or consumer confidence, as suggested by BAT. Specifically, it's important to consider any unintended consequences of BAT's actions and the potential for media coverage to undermine trust in electronic cigarettes among retailers and consumers, which could lead to a return to a product that causes tens of thousands of deaths each year.


Any statement made by BAT regarding their commitment to harm reduction must now be called into question. Their move to withdraw products to meet compliance targets may lead e-cigarette users to resume smoking. Regardless of the scale, BAT is directly calling for actions that may increase the dangers of smoking.


The media failed to report this detail and did not engage in balanced dialogue with retailers and wholesalers who have already taken steps to address these issues. This led them to too quickly portray electronic cigarettes as a "negative news story," in a coordinated manner.


As part of the executive group, IBVTA will always act according to our responsibilities and with the interests of our members and stakeholders in mind. However, we will never exceed our authority. As a trade association, one of our roles is to ensure our members understand their legal obligations and broader responsibilities, by providing guidance and other tools to help them meet these requirements, and ensuring our members are indeed meeting them.


We will not act as a law enforcement agency nor attempt to mimic their actions. Regardless of the source of information, we will communicate any non-compliant issues related to the field to the relevant authorities.


Reference:


The IBVTA has issued a statement in response to recent media reports regarding vape products that are allegedly overfilled. The statement aims to clarify the association's position on this matter and to provide reassurance to consumers.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain's cigarette volumes declined 5.2% year over year in August 2026, according to government data cited by UBS and reported by Investing.com on October 7. British American Tobacco's volumes fell 14.5%, followed by Imperial Brands at 8.8%, Philip Morris International at 6.6% and Japan Tobacco at 4.6%. JTI was the only one of the four companies to gain cigarette market share, rising six basis points to 26.7%. In France, official customs data showed an unadjusted 3.7% decline in cigarette deliveries. Adjusting for the difference in delivery days produces a decline of approximately 8.3%, consistent with the UBS figure. The bank also estimated the earnings exposure of major tobacco companies to both markets.
Market
Oct.13
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s state of Victoria has activated new powers allowing Tobacco Licensing Victoria and police to shut premises suspected of selling, supplying or possessing illicit tobacco for up to 90 days. Longer closures can be ordered by a magistrates’ court. Businesses subject to closure orders must generally cease all trading and will be placed on a public list. Breaching a closure order can carry penalties of up to A$2.5 million and 20 years in prison.
Sep.10